Also found in: Medical, Wikipedia.


A drug, C31H33N3O6S, that acts as a leukotriene receptor antagonist, reduces the inflammatory process, and is used in the treatment of asthma.

[zafir- (perhaps ultimately alteration of sulfonyl) + -lukast, leukotriene receptor antagonist suff. (from rearrangement of (anti)as(thmatic) l(e)uk(otriene receptor antagonis)t).]


n zafirlukast m
Mentioned in ?
References in periodicals archive ?
Under the terms of the agreement, Hovione will provide expertise on chemistry, particle engineering, formulation, device and GMP manufacturing to develop and manufacture Zafirlukast Dry Powder Inhaler (DPI), which will be delivered using its proprietary device.
P-14) Zafirlukast release from electrospun rubbery fiber mats.
Like zafirlukast, montelukast is a competitive antagonist for the cysteinyl leukotrienes.
Zafirlukast treatment for acute asthma: Evaluation in a randomized, double-blind, multicenter trial.
Bununla birlikte bu olgularda montelukast ve zafirlukast gibi LT reseptor antagonistlerinin anjiyoodem ataklarini onlediginin de gosterilmesi uzerine sisteinil LT'lerin de patogenezde rol oynayabileceginden bahsedilmistir (40).
Montelukast, marketed under the brand name Singulair, and zafirlukast (Accolate) are the most popular of the LTRAs.
Zafirlukast ve diger lokotriyen inhibitorleri ile Churg-Strauss sendromu arasinda bir iliski saptanmis, ancak bu iliski montelukast ile gorulmemistir.
The FDA, which issued the call in mid June, said the reported neuropsychiatric events included cases of agitation, aggression, anxiety, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal ideation and behavior, and tremor in patients using montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo, Zyflo CR).
Of the 96 women who took a leukotriene antagonist, 72 received montelukast; 22, zafirlukast (another leukotriene antagonist marketed as Accolate); and 2, both medications.
Montelukast (Singulair) and zafirlukast (Accolate) are two examples of leukotriene modifiers.
Montelukast (Singulair--MSD) and zafirlukast (Accolate--Astra Zeneca) are LTRAs, which are the most recently introduced class of anti-asthma agents.
As confirmed in daily diaries and by research staff, 14 subjects were not taking anti-inflammatory controller medications and 31 were [inhaled corticosteroids (ICS) and antileukotrienes (leukotriene receptor antagonists zafirlukast and montelukast)].